Effect of Hibiscus Sabdariffa Calyx Extract on Haematologic Indices in Sickle Cell Anaemia In-vitro
Click to view file (PDF)


Antisickling effect, Hibiscus sabdariffa calyx extract, MCHC, MCV, MPV, Gardos channel blocker

How to Cite

Mojiminiyi, P. F., Pereye, B., Ndakotsu, M., Ndodo, N., Ikhuenbor, D., & Igbokwe, V. (2022). Effect of Hibiscus Sabdariffa Calyx Extract on Haematologic Indices in Sickle Cell Anaemia In-vitro. African Journal of Biomedical Research, 25(2), 261–264. https://doi.org/10.4314/ajbr.v25i2.22


We hypothesised that the calyx extract of Hibiscus sabdariffa (HS) may have antisickling potential on account of its calcium antagonistic and antioxidants effects. Five ml of blood was collected from sickle cell anaemia (SCA) patients (n=11). 50µL of blood was incubated with 50µL each of 0.l, 1 and 10mg/ml of HS before adding 50µL of 2% sodium metabisulphite (Na2S2O5) (protective assay). Also, 50µL Na2S2O5 was added to 50µL of blood and then incubated with 50µL each of 0.l, 1 and 10mg/ml of HS (reversal assay). In parallel, 50µL of blood each was incubated with 50µL of 5 mg/ml hydroxyurea and 50µL of 0.9% NaCl (control) respectively. The mean cell haemoglobin concentration (MCHC), mean cell volume (MCV) and mean platelet volume (MPV) were determined. In both the protective and reversal assays, a significant (p<0.01 and p<0.05 respectively) decrease in MCHC was observed in the presence of HS. However, there was a significant (P<0.05) increase in MCV in the presence of HS in the reversal assay only. In the protective and reversal assays the MPV increased significantly (P<0.05 and P<0.01 respectively) in the presence of HS. These parameters showed no significant change in the presence of hydroxyurea. These results suggest that in the reversal assay HS may have antisickling properties by lowering the MCHC and increasing MCV and thereby reducing haemoglobin S concentration and polymerization. This further suggests that HS may have a Gardos channel inhibitory effect. However, the increase in MPV suggests that HS may be toxic at these concentrations.

Click to view file (PDF)


Adegunloye B.J, Omoniyi J.O, Owolabi O.A, Ajagbonna O.P, Sofola O.A and Coker H.A.B (1996). Mechanisms of the blood pressure lowering effect of the calyx extract of Hibiscus sabdariffa in rats. Afr J Med Sci. 25: 235–238.

Adejumo O.E, Ayoola M.D, Kolapo L.A, Orimoyegun V.O and Olatunji P.O (2011). Antisickling activities of extracts of leaf, seed and seed pod of Garcinia kola Heckel. African Journal of Pharmacy and Pharmacology. Vol. 5(1), pp. 48-52. Available online http://www.academicjournals.org/ajpp DOI: 10.5897/AJPP10.052 ISSN 1996-0816 ©2011 Academic Journals.

Adejumo O.E, Kolapo A.L and Folarin A.O (2012). Moringa oleifera Lam. (Moringaceae) grown in Nigeria: In vitro antisickling activity on deoxygenated erythrocyte cells. J Pharm Bioallied Sci. 4(2):118-122. doi:10.4103/0975-7406.94812.

Akohoue S, Shankar S, Milne G, Morrow J, Chen K.Y and Buchowski M.S (2007). Energy Expenditure, Inflammation, and Oxidative Stress in Steady-State Adolescents with Sickle Cell Anemia. Pediatr Res 61, 233–238 https://doi.org/10.1203/pdr.0b013e31802d7754.

Alsayed A.M.A, Zhang B.L, Bredeloux P, Boudesocque-Delaye L, Yu A, Peineau N, Enguehard-Gueier C, Ahmed E.M, Pasqualin C and Maupoil V (2020). Aqueous Fraction from Hibiscus sabdariffa Relaxes Mesenteric Arteries of Normotensive and Hypertensive Rats through Calcium Current Reduction and Possibly Potassium Channels Modulation. Nutrients, 12, 1782; doi:10.3390/nu12061782.

Amin M.A, Amin A.P and Kulkarni H.R (2004). Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease. Ann Hematol. 83(6):331-335. doi:10.1007/s00277-003-0833-8.

Antwi-Boasiako C, Dankwah G.B, Aryee R, Hayfron-Benjamin C, Donkor E.S, and Campbell A.D (2019). Oxidative Profile of Patients with Sickle Cell Disease. Medical sciences (Basel, Switzerland), 7(2), 17. doi:10.3390/medsci7020017.

Bender M.A. Sickle Cell Disease. 2003 Sep 15 [Updated 2021 Jan 28]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1377/

Celik T, Unal S, Ekinci O, Ozer C, Ilhan G, Oktay G, and Arica V (2015). Mean platelet volume can predict cerebrovascular events in patients with sickle cell anemia. Pakistan journal of medical sciences, 31(1), 203–208. https://doi.org/10.12669/pjms.311.4104.

Charache S, Terrin M.L, Moore R.D, Dover G.J, Barton F.B, Eckert S.V, McMahon R.P, and Bonds D.R (1995). Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med. 332(20):1317-1322. doi:10.1056/NEJM199505183322001.

Charache S. (1997). Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. Semin Hematol. 34(3 Suppl 3):15-21.

Cheesbrough M. (2006). District laboratory practise in Tropical Countries. Second Edition update, Part 2. Pg. 335-336 Cambridge University Press.

Chu S.G, Becker R.C, Berger P.B, Bhatt D.L, Eikelboom J.W, Konkle B, Mohler E.R, Reilly M.P and Berger J.S (2010). Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis. Journal of Thrombosis and Haemostasis, 8: 148-156. doi:10.1111/j.1538-7836.2009.03584.x

Eaton W.A and Bunn H.F (2017). Treating sickle cell disease by targeting HbS polymerization. Blood. 129 (20):2719–2726. doi:10.1182/blood-2017-02-765891.

Gardos G (1958). The function of calcium in the potassium permeability of human erythrocytes. Biochim Biophys Acta. 30(3):653-654. doi:10.1016/0006-3002(58)90124-0.

Halsey C. and Roberts I.A.G (2003). The role of hydroxyurea in sickle cell disease. British Journal of Haematology. 120: 177-186. doi:10.1046/j.1365-2141.2003.03849.x

Hebbel R.P, Eaton J.W, Balasingam M and Steinberg M.H (1982). Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest. 1982. 70:1253–1259. 5194.

Hirunpanich V, Utaipat A, Morales N.P, Bunyapraphatsara N, Sato H, Herunsale A and Suthisisang C (2006). Hypocholesterolemic and antioxidant effects of aqueous extracts from the dried calyx of Hibiscus sabdariffa L. in hypercholesterolemic rats. J Ethnopharmacol. 103 (2): 252-260.

Ibrahim H, Sani F.S, Danladi B.H, and Ahmadu A.A (2007). Phytochemical and antisickling studies of leaves of Hymenocardia acida Tul (Euphorbiaceae). Pakistan Journal of Biological sciences. 10(5): 788-791.

Imaga N.O.A (2010). A review on the use of phytomedicines as effective therapeutic agents in sickle cell anemia, Scientific research and essays. 5(24)3803-3807.

Jinna S and Khandhar P.B (2019). Hydroxyurea Toxicity. [Updated 2019 Nov 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537209/

Khandekar A, Acharya S and Shukla S (2018). Mean Platelet Volume as a Prognostic Indicator in Sickle Cell Anaemia. International Journal of Recent Surgical and Medical Sciences, January-June 4(1):5-9.

Klings E.S and Farber H.W (2001). Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respir Res. 2:280–285.

Klings E.S, Christman B.W, McClung J, Stucchi A.F, McMahon L, Brauer M question and Farber H.W (2001). Increased F2 isoprostanes in the acute chest syndrome of sickle cell disease as a marker of oxidative stress. Am J Respir Crit Care Med. 164:1248–1252.

McCarthy E.F (1943). The oxygen affinity of human maternal and foetal haemoglobin. The Journal of physiology. 102(1), 55–61. https://doi.org/10.1113/jphysiol.1943.sp004014.

Oduola T, Adeniyi F.A.A, Ogunyemi E.O, Bello I.O. and Idowu T.O.O (2006). Antisickling agent in an extract of unripe pawpaw (Carica papaya): Is it real? African Journal of Biotechnology. 5(20)1947-1949. Available online at http://www.academicjournals.org/AJB ISSN 1684–5315 © 2006 Academic Journals.

Owolabi O.A, Adegunloye B.J, Ajagbona O.P, Sofola O.A and Obiefuna P.C.M (1995). Mechanism of Relaxant Effect Mediated by an Aqueous Extract of Hibiscus sabdariffa Petals in Isolated Rat Aorta. Int J Pharmacognosy. Volume 33 (3):210-214.

Serjeant G.R and Serjeant B.E (2001). Sickle cell disease, 3rd edition, Oxford medical publications, Pg. 510-524. Oxford University press.

Steinberg M.H (1999). Management of Sickle Cell Disease, N Engl J Med. 340:10211030, DOI: 10.1056/NEJM199904013401307.

Steinberg M.H, Lu Z-H, Barton F.B, Terrin M.L, Charache S and Dover G.J (1997). Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea: Multicenter Study of Hydroxyurea. Blood. 89:1078-1088.

Stuart J, Mojiminiyi F.B.O, Stone P.C.W, Culliford S.J and Ellory J.C (1994). Additive in vitro effects of anti‐sickling drugs. Br J Haematol. 86: 820-823.

Usoh I.F, Akpan E.J, Etim E.O, and Farombi E.O (2005). Antioxidant actions of dried flower extracts of hibiscus sabdariffa l. on sodium arsenite-induced oxidative stress in rats. Pakistan Journal of Nutrition 4(3): 135-141, ISSN 1680-5194.

Vizioli L, Muscari S and Muscari A (2009). The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. International Journal of Clinical Practice, 63: 1509-1515. doi:10.1111/j.1742-1241.2009.02070.x

World health organization (2005) Executive board, Provisional agenda item 4.8 EB117/34, 117th Session.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2022 African Journal of Biomedical Research